Folic acid has therapeutic effects in rats with HFD-induced NAFL, as well as a function in modulating hepatic miR-21, -34a, and -122 and their target genes (HBP1, SIRT1, and SREBP-1c, respectively). The gene discussed is SIRT1; the disease is non-alcoholic fatty liver.